We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




New Tuberculosis Test Is Faster and More Accurate

By HospiMedica staff writers
Posted on 19 Oct 2006
A simple and rapid new tuberculosis (TB) test is more sensitive, faster, and cheaper to perform than current culture-based tests.

The test, called microscopic-observation drug-susceptibility (MODS), was developed by scientists from the Johns Hopkins Bloomberg School of Public Health (Baltimore, MD, USA), the Imperial College London (UK), Universidad Peruana Cayetano Heredia, (Lima, Peru), and other institutions. More...


A study was carried out to determine the efficacy of the test. From April 2003 to July 2004, the study authors collected 3,760 sputum-saliva mixed with respiratory discharge-in order to complete sensitivity and susceptibility studies of the MODS test. All samples were decontaminated and then used for parallel MODS testing, as well as for two current gold standard TB tests: the Lowenstein-Jensen culture and automated mycobacterial culture, using the MBBacT system of Organon Technika (Cambridge, UK).

In order to test the samples using MODS, the scientists observed the cultures under an inverted light microscope for 40 days. The sensitivity of detecting TB was 97.8 % for MODS culture, 89 % for automated mycobacterial culture and 84 % for Lowenstein-Jensen culture. The median time for detection of TB was seven days for MODS culture, 13 days for automated mycobacterial culture, and 26 days for Lowenstein-Jensen culture.

The TB antibiotics isoniazid, rifampin, ethambutol, and streptomycin were added to the cultures in order to detect drug-resistant TB. Compared to standard culture reference methods, drug-resistant susceptibility agreement for MODS was 100% for rifampin, 97% for isoniazid, 99% for rifampin and isoniazid, (combined for multi-drug resistance), 95% for ethambutol, and 92% for streptomycin. MODS results were available, on average, in seven days, making them clinically relevant. Standard tests for TB antibiotics can take up to several months.

The MODS test relies on three principles: Mycobacterium tuberculosis grows faster in liquid medium than in solid medium; the bacteria grow in characteristic tangles or coils that can be seen microscopically in liquid medium; and the ability to incorporate drugs permits rapid and direct drug-susceptibility testing at the same time as the detection of bacterial growth.

The authors of the study, which was published in the October 12, 2006, issue of the New England Journal of Medicine, expect MODS will have a major impact in developing countries where resources are limited.



Related Links:
Johns Hopkins Bloomberg School of Public Health
Imperial College London
Universidad Peruana Cayetano Heredia

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Resorbable Bovine Collagen Membrane
GenDerm
Gas Analyzer
GE SAM
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Clinical LLM Performance Improves by >300% When Provided with High-Quality Real-World Evidence in New Precision Medicine Benchmark (Photo courtesy of Atropos Health)

New Benchmark Highlights Evidence Gaps in AI Responses to Clinical Questions

Many clinical decisions still rely on limited evidence, while most artificial intelligence benchmarks overlook the patient context that shapes real-world care. General large language models can also struggle... Read more

Critical Care

view channel
Image Credit: Adobe Stock

New ECG Foundation Model Enables Broad Cardiac Diagnosis and Risk Prediction

Electrocardiograms are central to cardiovascular decision-making, but conventional artificial intelligence models are often trained for narrow tasks, such as detecting a single arrhythmia.... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.